Neuropathological findings in early onset Alzheimer disease (PS1-E280A mutation);Hallazgos neuropatologicos en la enfermedad de Alzheimer de inicio temprano (mutacion E280A-PS1)

Revista de Neurologia

Volumn 29, Issue 1, 1999, Pages 1-6

  Duque Castano A ^a   Roldan M I ^a   Arango Viana, J C ^a   Arcos Burgos, M ^b   Cubillo, H ^b   Lopera, F ^b  

^a Hospital Universitario San Vicente de Paul   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Alzheimer disease; Antioquia; Brain atrophy; Colombia; Genetics; Neurofibrillary tanggles; Presenilin; Presenilin 1; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ATROPHY; BRAIN WEIGHT; CEREBELLUM; CLINICAL ARTICLE; COLOMBIA; DISEASE COURSE; FEMALE; GENE MUTATION; GENEALOGY; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; ONSET AGE; SENILE PLAQUE; ATROPHY; BRAIN; BRAIN CORTEX; DOMINANT GENE; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; POINT MUTATION; ULTRASTRUCTURE;

ADULT; AGE OF ONSET; ALZHEIMER DISEASE; ATROPHY; BRAIN; CEREBRAL CORTEX; COLOMBIA; FEMALE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; ORGAN SIZE; POINT MUTATION; PRESENILIN-1; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX;

EID: 0033566262     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2901.99122     Document Type: Article

References (43)

1. Katzman R. Alzheimer's Disease. N Engl J Med 1986; 314: 964-73.
2. Berg L, Mckeel DW Jr, Miller JP, Bati J, et al. Neuropathological indexes of Alzheimer's Disease in demented and nondemented persons aged 80 years and older. Arch Neurol 1993; 50: 349-58.
3. Nalbantoglu J, Lacoste-Royal G, Gauvreau D. Genetic factors in Alzheimer's Disease. J Am Geriatr Soc 1990; 38: 564-8.
4. Cummings BJ, Eike SJ, Shankle R. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's Disease. Neurobiol Aging 1996; 17: 921-33.
5. Hendriks L, van Dujn C, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992; 1: 218-21.
6. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's Disease. Nature 1991; 349: 704-6.
7. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's Disease. Science 1991; 254: 97-9.
8. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a novel gene baring missense mutations in early onset familial Alzheimer's Disease. Nature 1995; 375: 754-60.
9. Barton AJ, Cerok BW, Karran EH, et al. Alteration in brain presenilin 1 mRNA expression in early onset familial Alzheimer's Disease. Neurodegeneration 1996; 5: 213-8.
10. Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's Disease: genetic and clinicopathological description. Ann Neurol 1994; 36: 362-7.
11. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's Disease locus. Science 1995; 269: 973-7.
12. Bird TD, Levy-Lahad E, Poorkaj P, et al. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Ann Neurol 1996; 40: 932-6.
13. Sandbrink R, Hartmann T, Masters CL, et al. Genes contributing to Alzheimer's disease. Mol Psychiatry 1996; 1: 27-40.
14. Lendon CL, Martínez A, Berhens MI, et al. The E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Hum Mutat 1997; 10: 186-95
15. Cornejo W, Lopera F, Uribe C, et al. Descripción de una familia con demencia presenil tipo Alzheimer. Acta Médica Col 1987; 12: 55-61.
16. Lopera F, Arcos M, Madrigal L, et al. Demencia tipo Alzheimer con agregación familiar en Antioquia, Colombia. Acta Neurol Col 1994; 2: 173-87.
17. Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (s182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995; 11: 219-22.
18. Lemere C, Lopera F, Kosik K, et al. The E280A presenilin 1 Alzheimer mutation produces increased Ab42 deposition and severe cerebellar pathology. Nat Med 1996; 2: 1146-50.
19. Lopera F, Ardila A, Martínez A, et al. Clinical features of early-onset Alzheimer's Disease in a large kindred with an E280A presenilin 1 mutation. JAMA 1997; 277: 793-9.
20. Alzheimer A. Über eine eigenartige Erkankung der Hirnrinde. Gesamte Psych 1907; 64; 146-8.
21. Burger P, Scheithauer B, Vogel F. Surgical pathology of the nervous system and its coverings. 3 ed. New York: Churchill Livingstone; 1991. p. 469-501.
22. Mckeel DW Jr, Gado M. A visual standards based system for scoring Alzheimer and aging-related human brain atrophy at autopsy. Brain Pathol 1994; 4: 544-50.
23. Brion J. The pathology of the neuronal cytoskeleton in Alzheimer's Disease. Biochem Biophys Acta 1992; 1160: 134-42.
24. Braak H, Braak E. Occurrence of neuropil threads in the senile human brain and in Alzheimer's Disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986; 65: 351-6.
25. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's Disease. Cerebral Cortex 1991; 1: 103-16.
26. Kalaria RN, Cohen DL, Premkuarnar D. Cellular aspects of the inflammatory response in Alzheimer's Disease. Neurodegeneration 1996; 5: 497-503.
27. Mann DM. Pyramidal nerve cells loss in Alzheimer's Disease. Neurodegeneration 1996; 5: 423-7.
28. Reyes MG, Faraldi F, Chandran R, et al. Histopathology of the sustantia nigra in Alzheimer's Disease. Panminerva Med 1996; 38: 8-14.
29. Gómez T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's Disease. Ann Neurol 1997; 41: 17-24.
30. Harman D. A hypothesis on the pathogenesis of Alzheimer's Disease. Ann N Y Acad Sci 1996; 786: 153-68.
31. Yamaguchi CH, Sugihara S, Ishiguro K, et al. Immunohistochemical analysis of COOH-termini of amyloid beta protein using end-specific antisera for Ab-40 and Ab42 in Alzheimer's Disease. Amyloid Int J Clin Invest 1995; 2: 7-16.
32. Fifkova E, Morales C. Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Physiol 1992; 42: 69-79.
33. Fukutani Y, Cairns NJ, Rossor MN, et al. Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's Disease. Neurosci Lett 1996; 214: 133-6.
34. Mirra SS, Heiman A, MckeeL D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's Disease. Neurology 1991; 41: 479-86.
35. Khachaturian ZS. Diagnosis of Alzheimer's Disease. Arch Neurol 1985; 42: 1097-105.
36. Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol 1991; 82: 239-59.
37. West M. New stereological methods for counting neurons. Neurobiol Aging 1993; 14: 275-85.
38. Hasselmo ME. A computational model of the progression of Alzheimer's Disease. MD Comput 1997; 14: 181-91.
39. Hibbard LS, Mckeel DW Jr. Automated identification and quantitative morphometry of the senile plaques of Alzheimer's Disease. Anal Quant Cytol Histol 1997; 19: 123-38.
40. Everall IP, Deteresa R, Terry R. Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer's Disease. J Neuropathol Exp Neurol 1997; 56: 1202.
41. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988; 24: 653-9.
42. Mann DMA. Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid b protein only in the form of ab42-43. Neurodegeneration 1996; 5: 115-20.
43. Griffin WS, Sheng J, et al. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995; 54: 276-81.